GlassScriptPhysician profile
Tammy Jo Bucari
NPI 1174590111
$2,545.57
in general payments reported to CMS, 2019-2025
26 companies · $491 in 2025
The $491 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $418 · 2022: $257 · 2023: $755 · 2024: $624 · 2025: $491.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,870.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,870.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $587.82 | 2021-2025 | |
| Amgen INC. | $251.65 | 2021-2024 | Repatha |
| Impulse Dynamics (USA) INC. | $237.89 | 2022-2024 | Optimizer, Optimizer |
| Merck Sharp & Dohme LLC | $230.58 | 2021-2025 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $174.11 | 2021-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $164.70 | 2022-2025 | Farxiga |
| Novo Nordisk INC | $124.76 | 2022-2024 | Ozempic, Rybelsus, Wegovy |
| Medtronic, INC. | $112.89 | 2025 | Corevalve Evolut R |
| Pfizer INC. | $109.70 | 2021-2025 | |
| Boston Scientific Corporation | $106.02 | 2023-2024 | Watchman Access System, Bodyguardian, Watchman Flx |
| Amarin Pharma, INC. | $89.71 | 2021-2023 | |
| Lexicon Pharmaceuticals, INC. | $76.46 | 2024 | |
| Abbott Laboratories | $47.05 | 2022-2023 | Mitraclip |
| Abiomed | $25.73 | 2023 | Impella |
| Astellas Pharma US INC | $23.99 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $21.94 | 2023 | |
| Alnylam Pharmaceuticals INC. | $18.60 | 2025 | Onpattro |
| Janssen Pharmaceuticals, INC | $18.50 | 2023 | Xarelto |
| Inspire Medical Systems, INC. | $17.00 | 2024 | Inspire |
| Kestra Medical Technology Services, INC. | $16.70 | 2024 | Assure Wcd |
| Kiniksa Pharmaceuticals, LTD. | $16.44 | 2023 | Arcalyst |
| Scpharmaceuticals INC. | $16.11 | 2023 | |
| Esperion Therapeutics, INC. | $15.61 | 2021 | |
| Atricure, INC. | $15.40 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $14.72 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $11.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tammy Bucari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.